Source: NEW YORK (Reuters)
GlaxoSmithKline Plc fired another salvo in defense of diabetes treatment Avandia on Tuesday by taking out full-page advertisements in at least a dozen major U.S. newspapers in an attempt to reassure patients of the safety of the widely used medicine.
The ads, which appeared in newspapers such as The New York Times, The Washington Post, USA Today and The Wall Street Journal, take the form of a letter to Avandia patients signed by Ronald Krall, chief medical officer of the world's second- largest drugmaker.
The unusual step comes a day before a scheduled U.S. congressional hearing on the Food and Drug Administration's role in evaluating the safety of Avandia, and a day after the first solid data became available on the medicine's eroding prescription numbers.
FULL STORY HERE
Zantac Lawsuit
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Please contact me if you would like a guest post considered for publication on my blog.